TRANSFORMING FRACTURE RISK
ASSESSMENT FOR CANCER PATIENTS
WITH VERTEBRAL METASTASES

Work Packages

Explore in detail by moving your mouse and clicking over the diagram
WP1 (UNIBO): Coordination and managementWP2 (IOR)• Data collection & harmonisation• Retrospective clinical stud(Train-METASTRA)WP3 (USD)Data-driven, physiology-based computational models, and DSS:• METASTRA-AI• METASTRA-VPH • METASTRA-VPH-TREAT• METASTRA-DSSWP4 (UNIBO)Verification& validation of computational models:• Biomechanical tests• Al verification• Mechanistic model validationWP5 (BHC)• Prospective clinical study(Validate-METASTRA)• Demonstration of computational models in clinical settingsWP6 (VCLS)• Regulatory roadmap for CE mark• Guidelines for stratification of patient fracture risk and personalised treatment (with AO)WP7 (EURICE)Innovation Management:• Communication• Dissemination• Exploitation